LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells by Targeting the miR-200a/β-Catenin Pathway

INTRODUCTION: Lung adenocarcinoma (LUAD), which is associated with high morbidity and mortality, is prone to cisplatin resistance, resulting in poor patient prognosis. Long non-coding RNAs (lncRNAs) have complex biological functions in a variety of tumors. Elucidating the underlying molecular mechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Weiwei, Yu, Xiuyi, Zeng, Ru, Chen, Lilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090201/
https://www.ncbi.nlm.nih.gov/pubmed/32256108
http://dx.doi.org/10.2147/CMAR.S240695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090201/
https://www.ncbi.nlm.nih.gov/pubmed/32256108
http://dx.doi.org/10.2147/CMAR.S240695

Ejemplares similares